Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries

R. Mezencev, M. Švajdler,

. 2017 ; 24 (3) : 400-410. [pub] 20160808

Jazyk angličtina Země Japonsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031523

BACKGROUND: Women diagnosed with breast cancer display higher propensity to develop second primary cancer in the contralateral breast (CBC). Identification of patients with increased risk of CBC and understanding relationships between hormone receptor (HR) statuses of the first and second breast cancers is desirable for endocrine-based prevention strategies. METHODS: Using 1992-2012 data from 13 SEER registries, the risk of developing CBC was determined as ratio of observed and expected second breast cancers (SIR). Association between HR statuses was examined by exploratory data analysis and multivariable logistic regression. RESULTS: Women with ER-positive and ER-negative breast cancers have increased risk of developing CBC with SIR values 2.09 (CI 95 = 1.97-2.21) and 2.40 (CI 95 = 2.18-2.63), respectively. ER statuses of the CBC are moderately positively associated. In metachronous CBC, most cases with ER-positive first cancers had ER-positive second breast cancers (81.6 %; CI 95 = 80.2-82.9 %); however, considerable proportion of cases with ER-negative first cancers had ER-positive second cancers (48.8 %; CI 95 = 46.2-51.4 %). CONCLUSIONS: Some women with ER-negative breast cancers may benefit from endocrine-based prevention of ER-positive CBC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031523
003      
CZ-PrNML
005      
20171122123847.0
007      
ta
008      
171025s2017 ja f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12282-016-0716-1 $2 doi
035    __
$a (PubMed)27502779
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ja
100    1_
$a Mezencev, Roman $u Integrated Cancer Research Center, School of Biology and Parker H. Petit Institute of Bioengineering and Biosciences, Georgia Institute of Technology, 310 Ferst DR, Atlanta, GA, 30329, USA. rmezencev3@gatech.edu.
245    10
$a Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries / $c R. Mezencev, M. Švajdler,
520    9_
$a BACKGROUND: Women diagnosed with breast cancer display higher propensity to develop second primary cancer in the contralateral breast (CBC). Identification of patients with increased risk of CBC and understanding relationships between hormone receptor (HR) statuses of the first and second breast cancers is desirable for endocrine-based prevention strategies. METHODS: Using 1992-2012 data from 13 SEER registries, the risk of developing CBC was determined as ratio of observed and expected second breast cancers (SIR). Association between HR statuses was examined by exploratory data analysis and multivariable logistic regression. RESULTS: Women with ER-positive and ER-negative breast cancers have increased risk of developing CBC with SIR values 2.09 (CI 95 = 1.97-2.21) and 2.40 (CI 95 = 2.18-2.63), respectively. ER statuses of the CBC are moderately positively associated. In metachronous CBC, most cases with ER-positive first cancers had ER-positive second breast cancers (81.6 %; CI 95 = 80.2-82.9 %); however, considerable proportion of cases with ER-negative first cancers had ER-positive second cancers (48.8 %; CI 95 = 46.2-51.4 %). CONCLUSIONS: Some women with ER-negative breast cancers may benefit from endocrine-based prevention of ER-positive CBC.
650    _2
$a senioři $7 D000368
650    _2
$a nádory prsu $x epidemiologie $x metabolismus $x patologie $x chirurgie $7 D001943
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a radikální mastektomie $7 D015409
650    _2
$a lidé středního věku $7 D008875
650    _2
$a sekundární malignity $x epidemiologie $x metabolismus $x patologie $7 D016609
650    _2
$a receptory pro estrogeny $x metabolismus $7 D011960
650    _2
$a rizikové faktory $7 D012307
650    _2
$a program SEER $7 D018426
655    _2
$a časopisecké články $7 D016428
700    1_
$a Švajdler, Marián $u The Faculty of Medicine and Faculty Hospital in Pilsen, Šikl's Department of Pathology, Charles University in Prague, Pilsen, Czech Republic. Bioptická laboratoř, s.r.o., Pilsen, Czech Republic.
773    0_
$w MED00173013 $t Breast cancer (Tokyo, Japan) $x 1880-4233 $g Roč. 24, č. 3 (2017), s. 400-410
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27502779 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171122124007 $b ABA008
999    __
$a ok $b bmc $g 1255116 $s 992550
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 24 $c 3 $d 400-410 $e 20160808 $i 1880-4233 $m Breast cancer $n Breast Cancer $x MED00173013
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...